Peter Ulvskjold, the Corporate Vice President of International Operations in Southeast Asia, highlights the challenges in the region facing diabetics and how Novo Nordisk is working to close the gaps in access and education for insulin in the region.
You have been overseeing South East Asia for about a year now. How would you characterize the pharmaceutical industry in this region?
"We work with patient organizations, endocrinology societies and government agencies that focus on chronic diseases. It is part of my responsibility to maximize the outcomes of these relationships and ultimately help people with diabetes live better lives."
